Intra-Cellular (ITCI) - Net earnings per share change in current year
Risks for Intra-Cellular Therapies (ITCI) are linked to the success of Caplyta and regulatory pressure. The 12-month EPS growth percentage on the GURU.Markets analytical chart captures profit dynamics, where the value of 121.50 characterizes this level. Cash flow stability is based on the chronic nature of the diseases, while investor confidence is supported by the effective scaling of sales by experienced management.
Analytical breakdowns and data insights for company Intra-Cellular Therapies Inc. (ITCI)
- market value and analyst target forecast:
- market capitalization indicators:
- book value of equity indicators:
- debt burden and liquidity indicators:
Debt to Equity Intra-Cellular Therapies|ITCI - Long-Term Debt to Equity|Short-Term Debt to Equity Intra-Cellular Therapies|ITCI - Company Total Debt|Debts to Book Capitalization Intra-Cellular Therapies, Inc.|ITCI - Company Long-Term Debt|Company Short-Term Debt Intra-Cellular Therapies|Quick Ratio intracellulartherapies.com
- net income and valuation ratios data:
ITCI - Company Net Income|Expected Net Income Intra-Cellular Therapies|ITCI - Price to Earnings Ratio|Future Price to Earnings Multiple Intra-Cellular Therapies|ITCI - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Intra-Cellular Therapies|ITCI - Operating profit EBITDA|Earnings per share for the trailing year Intra-Cellular Therapies|ITCI - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months intracellulartherapies.com|ITCI - Earnings per share growth in current year|Expected earnings per share trend next year Intra-Cellular Therapies
- sales volume and revenue information:
Summary company analysis:Intra-Cellular Therapies
The stability of Intra-Cellular Therapies (ITCI) neuro-drug supplies through a network of contract sites minimizes capital expenditures, directly impacting net income. This annual earnings per share growth rate captures the percentage deviation of the current EPS from the value of the same period last year. While this indicator serves as a dynamic speedometer of efficiency, it requires correlation with the debt load to avoid overpaying for past successes.
Main competitors
Earnings per share growth rate in current year Biogen Idec (BIIB)|NBIX (neurocrine.com) - Earnings growth in current year|Earnings per share growth rate in current year regencellbioscience.com RGC|Net earnings per share growth this year AXSM (Axsome Therapeutics, Inc.)|ACAD (ACADIA Pharma) - Earnings per share increase in current year|Earnings growth in current year XENE (Xenon Pharmaceuticals Inc)|Net earnings per one share growth for the current year VKTX (Viking Pharma)|SUPN: Net earnings per share growth this year|Earnings per share increase in current year CPRX (catalystpharma.com)|DNLI: Earnings growth in current year|HRMY - Expected net earnings per share growth this year|Net earnings per share growth this year BHVN|AMLX: Earnings per share increase in current year|Earnings per share growth in current year Trevi Pharma (TRVI)|Expected net earnings per share growth this year praxismedicines.com|Earnings per share growth in current year Anavex AVXL|Expected net earnings per share growth this year CeriBell (CBLL)|PRTA - Earnings per share growth in current year|ALEC: Earnings per share growth in current year|Annexon (ANNX) - Earnings per share growth in current year|OMER: Net earnings per one share growth for the current year|NGNE (neurogene.com) - Earnings growth in current year|Earnings growth in current year AC Immune S.A.|Net earnings per share growth this year VYGR (Voyager Therapeutics, Inc.)|Net earnings per one share growth for the current year NMRA|Earnings per share growth in current year scilexholding.com SCLX|TVGN: Earnings per share growth this year|alphacognition.com - Earnings growth in current year|Cognition Therapeutics - Net earnings per one share growth for the current year|IKT: Earnings growth in current year|Net earnings per share growth this year Cassava Sciences, Inc.|ASRT (assertiotx.com) - Earnings growth in current year|Net earnings per share growth this year Coya Therapeutics (COYA)|Net earnings per share growth this year VTGN (Vistagen)|Expected net earnings per share growth this year Ovid Therapeutics Inc|Earnings growth in current year ABOS (Acumen Pharmaceuticals Inc.)|CRVO - Net earnings per share growth this year|Alterity Therapeutics Limited - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc|PEPG: Earnings growth in current year|Net earnings per share growth this year jupiterneurosciences.com|RLMD (relmada.com) - Earnings growth in current year|Earnings growth in current year Annovis Bio Corporation|Earnings growth in current year GRCE|AIFF: Earnings per share trend in current year|Earnings per share growth in current year Klotho Neurosciences KLTO|NRSN: Earnings per share growth this year|RVPH: Net earnings per share growth this year|Expected net earnings per share growth this year MetaVia MTVA|neuraxis.com (NRXS) - Earnings per share growth in current year|Helius Medical Technologies Inc. - Earnings per share increase in current year|PASG (Passage Bio, Inc.) - Earnings growth in current year|bionomics.com.au - Earnings per share trend in current year|Earnings growth in current year NERV|ATHA (Athira) - Earnings per share increase in current year|Addex Therapeutics - Net earnings per share growth this year|ALZN - Net earnings per share growth this year|Cyclerion Therapeutics, Inc. - Earnings growth in current year|Earnings per share increase in current year PTIX (Protagenic Therapeutics, Inc.)|KTTA (pasitheaclinics.com) - Net earnings per share growth this year|Earnings per share growth this year CRGT|Net earnings per share growth this year ATXI|Net earnings per share growth this year Brainstorm Cell (BCLI)|Net earnings per share growth this year CARA (Cara Therapeutics, Inc.)|Net earnings per share growth this year Chromocell Therapeutics Corp CHRO|Earnings growth in current year ELYM (Eliem Therapeutics, Inc.)|Net earnings per share change in current year Longboard Pharma|MRNS - Earnings per share growth in current year|NKGen Biotech, Inc. (NKGN) - Net earnings per share growth this year|NRBO (NeuroBo Pharmaceuticals, Inc.) - Net earnings per share growth this year|Sage Therapeutics - Earnings per share increase in current year|Earnings per share growth in current year Synaptogenix, Inc.|TRVN: Earnings per share increase in current year|Earnings growth in current year VIGL|Net earnings per share growth this year Anew Medical, Inc. WENA|Earnings per share growth in current year Cerevel Therapeutics CERE
